14/02/2017
Auris Medical Announces Proposed Public Offering of Common Shares and Warrants
Auris Medical Holding AG(NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that it is offering to sell common shares and warrants [...]
